 |
 | Vissza |
Liszkay Gabriella; Benedek Angela; Polgár Csaba; Oláh Judit Magdolna; Holló Péter; Emri Gabriella; Csejtei András; Kenessey István; Polányi Zoltán; Knollmajer Kata; Várnai Máté; Vokó Zoltán; Nagy Balázs; Rokszin György Aurél; Bajcsayné Fábián Ibolya; Barcza Zsófia; Gyulai Rolland Péter; Kiss Zoltán:
Significant improvement in melanoma survival over the last decade: A Hungarian nationwide study between 2011 and 2019.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 37 (5).
pp. 932-940.
ISSN 0926-9959
(2023)
Liszkay Gabriella; Kiss Zoltán; Gyulai Roland; Oláh Judit Magdolna; Holló Péter; Emri Gabriella; Csejtei András; Kenessey István; Benedek Angela; Polányi Zoltán; Nagy-Erdei Zsófia; Daniel Andrea; Knollmajer Kata; Várnai Máté; Vokó Zoltán:
Changing Trends in Melanoma Incidence and Decreasing Melanoma Mortality in Hungary Between 2011 and 2019: A Nationwide Epidemiological Study.
FRONTIERS IN ONCOLOGY, 10.
Terjedelem:10-Azonosító:612459.
ISSN 2234-943X
(2021)
Ladányi Andrea; Papp Eszter; Mohos Anita; Balatoni Tímea; Liszkay Gabriella; Oláh Judit Magdolna; Varga Anita; Lengyel Zsuzsanna; Emri Gabriella; Ferrone Soldano:
Role of the anatomic site in the association of HLA class I antigen expression level in metastases with clinical response to ipilimumab therapy in patients with melanoma.
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 8 (1).
Terjedelem: 8-Azonosító: e000209.
ISSN 2051-1426
(2020)
Balatoni Tímea; Mohos Anita; Papp Eszter; Sebestyén Tímea; Liszkay Gabriella; Oláh Judit Magdolna; Varga Anita; Lengyel Zsuzsanna; Emri Gabriella; Gaudi István; Ladányi Andrea:
Tumor-infiltrating immune cells as potential biomarkers predicting response to treatment and survival in patients with metastatic melanoma receiving ipilimumab therapy.
CANCER IMMUNOLOGY IMMUNOTHERAPY, 67 (1).
pp. 141-151.
ISSN 1432-0851
(2018)
